Illumina Inks Co-Marketing Pacts with Caliper, Sage Science for Next-Gen Sequencing Sample Prep | GenomeWeb

Illumina said today that it has inked separate co-marketing agreements with Caliper Life Sciences and Sage Science to promote use of those companies' sample prep systems in next-generation sequencing applications.

Under the first agreement, Illumina will promote Caliper's LabChip XT, a preparative microfluidic platform for separating DNA fragments of different sizes that uses multi-channel disposable chips to run up to four samples in less than 30 minutes. Caliper said that the platform was developed "with direct input" from Illumina.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.